neuraxpharm

Private

—N/Ahttps://neuraxpharm.com

Last Round

Debt

Jul 11, 2025

Last Round Size

$1.9B

Est. Valuation

$1.9B

Total Funding Raised

$1.9B

Company Overview

A specialty pharmaceutical company focused on the treatment of the central nervous system (CNS).

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Book a demo to explore historical pricing and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Book a demo

For institutional investors. Book with your work email.

neuraxpharm Comparables

Compare neuraxpharm with similar companies based on industry and business-model similarity.

No public comparables are available for neuraxpharm. Request access to learn about comparables coverage.

Book a demo

For institutional investors. Book with your work email.

neuraxpharm Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jul 11, 2025	Book a demo	Book a demo	Book a demo	Book a demo
Buyout/LBO	Sep 22, 2020	Book a demo	Book a demo	Book a demo	Book a demo
Buyout/LBO	Jul 8, 2016	Book a demo	Book a demo	Book a demo	Book a demo

Book a demo to see all 3 rounds

For institutional investors. Book with your work email.

neuraxpharm Filings

Explore SEC and related filing metadata, where available.

neuraxpharm filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—

Year Founded1985

Last FundingJul 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?